Multiple risk factors were associated with denials and longer wait times for biologic treatment in moderate to severe asthma, ...
Adherence was deemed intermittent based on heatmaps. SAN DIEGO — Across six asthma biologics, adherence differed by the therapy given and was often low or irregular based on three adherence ...
Until relatively recently the development of novel asthma anti-inflammatory therapy based on targeting cytokines has proven to be, for the most part, disappointing. The majority of biologics have ...
AstraZeneca is hopping on the pickleball craze for the latest iteration of its Stepping Back Out campaign for asthma ...
Biologics prescribed for EA include omalizumab ... the white blood cells that cause this type of asthma, can attack other parts of your body. One common target is your gastrointestinal (GI ...
A 12-month interim analysis of the AGILE Phase III extension study confirms the long-term safety and efficacy of twice-yearly ...
Wheezing is a hallmark symptom of asthma, but not everyone experiences it. You may have a cough or more silent symptoms of asthma. In rare cases, the absence of wheezing could suggest severe asthma.
The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...
Learn the vital steps to take when someone experiences a severe asthma attack, from recognizing danger signs to administering ...
For individuals with severe asthma, biologics—a new type of treatment targeting ... Asthma is a chronic inflammatory disease that affects the lungs. In a child with asthma, the airways are very ...
For individuals with severe asthma, biologics—a new type of treatment targeting ... Asthma is a chronic inflammatory disease that affects the lungs. In a child with asthma, the airways are very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results